These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

346 related items for PubMed ID: 6290699

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. [Studies on penetration of antibiotics to gallbladder tissue and bile, its surgical significance. Mainly with cefmenoxime].
    Tsuburaya H, Watanabe I, Endo S, Oikawa M.
    Jpn J Antibiot; 1985 Jan; 38(1):31-40. PubMed ID: 3857360
    [Abstract] [Full Text] [Related]

  • 3. [Therapeutic effects of cefotiam in biliary tract infections].
    Ozawa K, Nakagawa H, Sato O, Maekawa T, Wagai K, Kidokoro T.
    Jpn J Antibiot; 1982 May; 35(5):1163-6. PubMed ID: 6290700
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [Biliary tract infections and antibiotics concentration of cefotiam in gallbladder tissue and bile (author's transl)].
    Saito S, Yoshida M.
    Jpn J Antibiot; 1982 Apr; 35(4):1057-62. PubMed ID: 6285023
    [Abstract] [Full Text] [Related]

  • 6. [Clinical observation on the transport of cefotiam into the bile and gall bladder tissue].
    Tohyama K, Miyake T, Morinaga H, Futakuchi S, Izumi M, Yamanaka T, Egami H, Yamane T, Ga S, Fujishima K.
    Jpn J Antibiot; 1983 Jun; 36(6):1439-42. PubMed ID: 6317904
    [Abstract] [Full Text] [Related]

  • 7. [Clinical studies on the transference of cephem-type antibiotics into bile and gallbladder tissues with special reference to cefotiam and cefmenoxime].
    Shiozaki H, Aeba S, Matsumoto H, Usui R, Totsuka S, Kusaba T, Mishima T, Hasegawa S, Iijima K, Okano A.
    Jpn J Antibiot; 1986 Mar; 39(3):751-60. PubMed ID: 3461175
    [Abstract] [Full Text] [Related]

  • 8. [Concentrations of cefmenoxime and cefotiam in the bile and gallbladder tissue following intravenous administration in patients with biliary tract diseases].
    Shoda Y, Matsuyama S, Takarada A, Arai M, Nagashima K, Nakano G, Nakamura T, Kamisaka K, Matsuzawa T, Yoshino T.
    Jpn J Antibiot; 1986 May; 39(5):1259-72. PubMed ID: 3463776
    [Abstract] [Full Text] [Related]

  • 9. [Clinical studies on excretion in biliary tract with the antibiotic cefotiam].
    Yaita A, Kanamori H, Masuo K, Taniura H, Nakamura T.
    Jpn J Antibiot; 1985 Jun; 38(6):1566-70. PubMed ID: 3862879
    [Abstract] [Full Text] [Related]

  • 10. [Antibacterial potency of cefotiam based on the clinical effect, MIC and decrement of organisms in the sputum].
    Kawagoe M, Narushima K, Kitani A, Shibuya T, Hara M, Hosono K, Shitara M.
    Jpn J Antibiot; 1983 Aug; 36(8):2053-7. PubMed ID: 6317912
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [The antibacterial activity of new cephem antibiotics against clinical isolates. A comparison of the antibacterial activity of cefotaxime with 6 other antibiotics].
    Miwatani T, Takeda Y, Kotera K, Nishimura T, Takashima T, Hiromatsu K, Tabuki K, Fujimoto S, Kamiki T, Yoshizaki E, Yabuuchi E, Shimizu Y, Matsunaga K, Yamanaka K, Furuta I, Iimori M, Kodama J, Tanaka M, Maejima K, Nukina M, Takashima E, Takahashi M, Harikane O, Masutani T.
    Jpn J Antibiot; 1983 Feb; 36(2):260-76. PubMed ID: 6304368
    [Abstract] [Full Text] [Related]

  • 13. [Experimental study of the biliary excretion of antibiotic (cefotiam) in the presence of biliary tract obstruction (author's transl)].
    Yoshikawa N, Tsuji Y, Sato Y, Ikeda Y, Shinada Y, Kawanishi N, Tamaki A, Kasai Y.
    Jpn J Antibiot; 1979 Nov; 32(11):1101-6. PubMed ID: 513292
    [Abstract] [Full Text] [Related]

  • 14. [Comparison of sensitivity patterns of bacteria isolated from clinical materials to the 2d generation cephamycins and cephalosporins and clinical application of these antibiotics].
    Matsuo K, Uete T.
    Jpn J Antibiot; 1983 Jul; 36(7):1621-37. PubMed ID: 6317908
    [Abstract] [Full Text] [Related]

  • 15. [Evaluation of cefotiam in pediatric field (author's transl)].
    Iwai N, Sasaki A, Taneda Y, Inokuma K.
    Jpn J Antibiot; 1981 Jun; 34(6):1002-18. PubMed ID: 6270417
    [Abstract] [Full Text] [Related]

  • 16. [Antibacterial activities of cefotiam against various causative organisms isolated from clinical materials (author's transl)].
    Matsuoka A, Sumi K, Yoshimoto H, Takase M, Takashima S, Mimura K.
    Jpn J Antibiot; 1982 Apr; 35(4):993-1003. PubMed ID: 6285029
    [Abstract] [Full Text] [Related]

  • 17. [Fundamental and clinical studies on cefuzoname in the pediatric field].
    Toyonaga Y, Sugita M, Kawamura K, Seo K, Takahashi T, Hori M.
    Jpn J Antibiot; 1987 Apr; 40(4):843-65. PubMed ID: 3613094
    [Abstract] [Full Text] [Related]

  • 18. [Basic and clinical studies on cefotiam in the field of obstetrics and gynecology].
    Ninomiya K, Ohbayashi F, Hasegawa Y, Hamaya K, Nishio T.
    Jpn J Antibiot; 1982 Dec; 35(12):2812-21. PubMed ID: 6304363
    [Abstract] [Full Text] [Related]

  • 19. [Basic and clinical studies of cefotiam in neonates and premature infants].
    Iwata S, Sato Y, Kusumoto Y, Shiro H, Akita H, Nanri S, Oikawa T, Osano M, Sunakawa K.
    Jpn J Antibiot; 1986 Sep; 39(9):2407-20. PubMed ID: 3540358
    [Abstract] [Full Text] [Related]

  • 20. [Basic and clinical studies of cefotiam in the field of pediatrics (author's transl)].
    Toyonaga Y, Kurosu Y, Hori M.
    Jpn J Antibiot; 1981 May; 34(5):690-704. PubMed ID: 6270411
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.